STERIS’ (TSE:STE – Free Report) – Equities research analysts at Atb Cap Markets dropped their Q3 2025 earnings per share estimates for STERIS’ in a research report issued on Wednesday, June 11th. Atb Cap Markets analyst W. Syed now anticipates that the company will post earnings of $0.22 per share for the quarter, down from their prior forecast of $0.28. Atb Cap Markets also issued estimates for STERIS’’s Q4 2025 earnings at ($0.10) EPS, FY2025 earnings at $0.57 EPS, Q1 2026 earnings at $0.42 EPS, Q2 2026 earnings at $0.14 EPS, Q3 2026 earnings at $0.31 EPS, Q4 2026 earnings at ($0.02) EPS and FY2026 earnings at $0.84 EPS.
Separately, Raymond James lowered STERIS’ from a “moderate buy” rating to a “hold” rating in a research note on Wednesday, April 9th.
STERIS’ Price Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Further Reading
- Five stocks we like better than STERIS’
- How to Buy Cheap Stocks Step by Step
- RH Stock Rockets on Surprise Profit and Tariff Shift
- Technology Stocks Explained: Here’s What to Know About Tech
- Synopsys Stock Falls on China Ban, But Long-Term Outlook Holds
- 5 discounted opportunities for dividend growth investors
- Alphabet Enters a Bull Market: Is It Time to Buy?
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
